about-me variable
SafeBiologics and GaBI invites you to their event

KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US

About this event

KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US

Measures Taken for Improving Biosimilar Uptake and the Potential Role of Healthcare Providers and Patients
Wednesday, 29 June 2022 | 10:00 am – 12:00 pm (EDT)
Online event hosted by the Alliance For Safe Biologic Medicines and Generics and Biosimilars Initiative

Biosimilars have been in the market for 16 years since its first launch in 2006 in Europe, currently, there are 84 approvals in the EU and 35 in the US, representing almost 90% of the world market. While more biosimilars entering the healthcare system, there remains the need for broader information share and regular discussions to clarify and alleviate the concerns of biosimilars use for physicians and patients, specifically on the issues of prescribing practice and switching of biosimilars.

An academic clinician with specialty in gastroenterology, a pharmacist, a patient advocate and a market access expert will share their experience with biosimilars, highlighting successes and challenges, their perspectives on prescribing and switching of biosimilars and measures to increase biosimilar adoption, including the role of healthcare providers.

Enhanced knowledge on biosimilars use will help provide more affordable treatment choices for patients.

Keynote speaker:

Impact of biosimilars in the US healthcare system and the path forward

Eric David Hargan, JD, Former United States Deputy Secretary of Health and Human Services

Moderator:

Steven Stranne, MD, JD, Foley Hoag LLP

Speakers:

Eric David Hargan, JD

Michael S Reilly, Esq

Ralph McKibbin, MD, FACP, FACG, AGAF

Professor Philip J Schneider, MS, FASHP, FASPEN, FFIP

Chad Pettit, MBA

Andrew Spiegel, Esq

To find out more about the webinar, click here to download the agenda

Don't miss out on this first ASBM/GaBI biosimilars event, REGISTER NOW!

Hosted by

  • Team member
    AG T
    Anthika GaBI Team member

  • Guest speaker
    G
    Michael S Reilly, Esq Executive Director @ Alliance for Safe Biologic Medicines

  • Guest speaker
    G
    Chad Pettit, MBA Executive Director, Marketing, Biosimilars Business Unit @ Amgen

  • Guest speaker
    G
    Eric David Hargan, JD Former Deputy Secretary @ Department of Health and Human Services (HHS)

  • Guest speaker
    G
    Philip Schneider Professor @ The Ohio State University College of Pharmacy

  • Guest speaker
    G
    Andrew Spiegel Board Chair @ World Patients Alliance

  • Guest speaker
    G
    Steven Stranne, MD, JD Partner @ FOLEY HOAG LLP

  • Team member
    T
    SafeBiologics and GaBI 2022 Webinar Program Committee

  • Guest speaker
    G
    Ralph McKibbin, MD, FACP, FACG, AGAF President @ Pennsylvania Society of Gastroenterology/Digestive Disease National Coalition

SafeBiologics and GaBI

Building trust in cost-effective treatments

The mission of GaBI is to foster the worldwide efficient use of high quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable health care.